XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 63 filers reported holding XENON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,059,087 | -14.3% | 26,859 | -21.6% | 0.01% | -20.0% |
Q3 2022 | $1,236,000 | +8.4% | 34,251 | -8.6% | 0.01% | +25.0% |
Q2 2022 | $1,140,000 | +9.0% | 37,474 | +9.5% | 0.01% | +14.3% |
Q1 2022 | $1,046,000 | -0.7% | 34,216 | +1.5% | 0.01% | 0.0% |
Q4 2021 | $1,053,000 | +85.7% | 33,696 | -9.3% | 0.01% | +75.0% |
Q3 2021 | $567,000 | -23.9% | 37,136 | -7.2% | 0.00% | -20.0% |
Q2 2021 | $745,000 | +1.2% | 40,017 | -2.7% | 0.01% | -16.7% |
Q1 2021 | $736,000 | +17.0% | 41,137 | +0.6% | 0.01% | 0.0% |
Q4 2020 | $629,000 | +36.1% | 40,897 | -2.0% | 0.01% | +20.0% |
Q3 2020 | $462,000 | -11.5% | 41,734 | +0.4% | 0.01% | -28.6% |
Q2 2020 | $522,000 | +10.8% | 41,567 | +0.1% | 0.01% | 0.0% |
Q1 2020 | $471,000 | -42.6% | 41,546 | -33.5% | 0.01% | -22.2% |
Q4 2019 | $820,000 | +37.4% | 62,509 | -5.7% | 0.01% | +28.6% |
Q3 2019 | $597,000 | -9.5% | 66,308 | -0.9% | 0.01% | -12.5% |
Q2 2019 | $660,000 | -3.2% | 66,937 | -0.2% | 0.01% | -11.1% |
Q1 2019 | $682,000 | +62.0% | 67,082 | +0.6% | 0.01% | +50.0% |
Q4 2018 | $421,000 | -44.2% | 66,704 | +16.8% | 0.01% | -40.0% |
Q3 2018 | $754,000 | +140.1% | 57,086 | -11.3% | 0.01% | +150.0% |
Q2 2018 | $314,000 | -0.3% | 64,357 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $315,000 | +77.0% | 64,357 | +2.3% | 0.00% | +100.0% |
Q4 2017 | $178,000 | +11.2% | 62,918 | +15.7% | 0.00% | 0.0% |
Q3 2017 | $160,000 | +42.9% | 54,371 | +52.6% | 0.00% | 0.0% |
Q2 2017 | $112,000 | +6.7% | 35,629 | +36.0% | 0.00% | 0.0% |
Q1 2017 | $105,000 | -34.4% | 26,203 | +25.9% | 0.00% | -33.3% |
Q4 2016 | $160,000 | -5.3% | 20,818 | -0.0% | 0.00% | 0.0% |
Q3 2016 | $169,000 | – | 20,820 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |